F16IL2

F16-IL2 · Philogen S.p.A.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for F16IL2, covering 2014-02-25 to 2022-07-21. Get the full timeline:

Most recent: Clinical Trial Update: F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]